Gan & Lee Pharmaceuticals.

SSE:603087.SS

55.83 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q12017 Q42017 Q22017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 1,058.837902.7783,500.171361.9992,552.991316.4892,093.4063,062.6912,743.9142,890.2672,960.5883,272.3243,390.7613,305.7083,100.2843,012.5322,789.752,824.8122,429.8673,019.708494.256483.217-1,178.23817.314665.117665.117
Short Term Investments 1,297.7011,500.4971,566.6874,507.1592,346.9814,536.6492,077.6081,533.9871,648.6131,635.951,817.2571,466.0031,556.2551,624.1831,203.2561,098.1041,144.504787.051,435.1211,200.1741,251.6581,058.2722,356.46107575
Cash and Short Term Investments 2,356.5382,403.2755,066.8584,869.1584,899.9724,853.1384,171.0154,596.6794,392.5274,526.2174,777.8454,738.3274,947.0164,929.8914,303.544,110.6363,934.2543,611.8623,864.9884,219.8831,745.9141,541.4891,178.23817.314665.117740.116
Net Receivables 342.595248.566275.461377.318291.764385.37416.189288.427235.629189.568135.954277.776750.606934.663726.812688.022592.493827.345561.719411.75550.952847.530504.657490.212490.212
Inventory 1,113.0631,052.9071,028.209950.338932.042860.506858.848749.457688.682648.646668.23732.718732.29651.329575.548578.063560.444493.482525.583527.862501.544471.3490212.319188.041188.041
Other Current Assets 88.07786.111117.893133.9291.2576.73542.1378.019303.54299.706258.068442.15344.704354.56759.859626.885797.9671,026.924710.042376.926343.439249.730454.727102.79327.793
Total Current Assets 3,900.2733,790.8586,488.4216,330.7336,215.0286,175.755,488.1815,712.5825,624.4015,664.1365,840.0976,190.9716,774.6166,870.4436,365.7596,003.6055,885.1575,959.6145,662.3315,536.4213,141.853,110.0981,178.231,970.2751,446.1631,446.163
Non-Current Assets:
Property, Plant & Equipment, Net 3,877.9383,882.0393,875.6233,906.2673,880.2273,915.0413,716.8213,709.3633,669.0363,661.3373,050.5262,818.1122,638.1272,595.372,579.0252,504.632,219.3122,149.0022,025.3741,930.5371,883.661,890.30201,391.311,198.9251,198.925
Goodwill 00000000000000000000000000
Intangible Assets 1,311.7941,190.8721,105.0981,098.7481,089.9121,091.1881,076.0771,072.1311,049.5721,026.0431,002.621939.567913.382872.485799.236790.878773.957769.623746.646737.446608.077591.3340214.486170.733139.843
Goodwill and Intangible Assets 1,311.7941,190.8721,105.0981,098.7481,089.9121,091.1881,076.0771,072.1311,049.5721,026.0431,002.621939.567913.382872.485799.236790.878773.957769.623746.646737.446608.077591.3340214.486170.733139.843
Long Term Investments -750.508-991.756-1,043.407439.664337.123334.658-1,745.442-1,503.987-1,618.613-1,605.95-1,787.257-1,436.003-1,324.922-1,392.825-1,003.256-790.747-675.893-321.003-971.694-739.367-943.471-696.0690000
Tax Assets 213.851206.935165.06157.013152.239168.953109.452114.193129.84138.2556.30341.20938.46330.80226.31127.10625.49914.9281,449.1111,214.6141,266.5621,073.64011.0863.9260
Other Non-Current Assets 3,731.0873,963.9691,630.82520.13345.42629.4342,179.9481,624.8611,741.6411,723.0962,238.1321,864.1131,877.4311,876.8871,489.3431,306.0121,419.449935.286118.71856.04747.40657.376-1,178.23156.198147.624182.441
Total Non-Current Assets 8,384.1628,252.0585,733.1995,621.8245,504.9275,539.2745,336.8565,016.5614,971.4764,942.7764,560.3254,226.9974,142.4823,982.723,890.6593,837.8793,762.3233,547.8353,368.1563,199.2772,862.2352,916.583-1,178.231,773.081,521.2081,521.208
Total Assets 12,284.43512,042.91612,221.62111,952.55711,719.95411,715.02310,825.03810,729.14310,595.87710,606.91210,400.42210,417.96910,917.09710,853.16310,256.4189,841.4849,647.4819,507.4499,030.4888,735.6986,004.0856,026.68103,743.3552,967.3722,967.372
Liabilities & Equity:
Current Liabilities:
Account Payables 112.917129.129111.03996.323107.433105.54289.74497.85986.49944.69358.15650.29233.79737.74130.3533.90417.90717.81420.97130.75428.930.65031.21427.08827.088
Short Term Debt 00000000000000000000000000
Tax Payables 11.8411.19118.8141.63110.2071.42122.10315.52612.6514.41313.64217.83460.927129.68837.34346.8949.89566.74188.00560.74455.489156.656070.14743.3920
Deferred Revenue 00030.8732.63952.992612.477668.567068.729114.9700439.721442.581523.006287.659381.999439.098349.945229.18298.5130267.526198.3570
Other Current Liabilities 668.458660.811676.822665.758532.072666.487558.209607.956644.558753.931373.594313.844319.32281.539-33.36423.601179.894256.852339.344273.719235.79180.2290234.451197.141240.533
Total Current Liabilities 793.215801.132806.675763.712682.351773.449717.656779.615743.706813.037560.362381.97414.044485.531476.914561.735311.436409.85510.932437.903320.179458.2210335.811267.621267.621
Non-Current Liabilities:
Long Term Debt 3.0563.3063.6723.7823.9095.4478.188.5268.0668.32713.42313.24713.04412.16613.76114.54614.88102.14202.2380.68300.28200
Deferred Revenue Non-Current 168.83168.924171.127175.024177.325179.626182.698185.037187.379187.635189.58165.253167.313141.977143.456145.562147.668125.769105.9267.72169.39471.067071.90571.0910
Deferred Tax Liabilities Non-Current 4.56412.11121.86219.2960-179.62611.44500017.60131.11127.15736.14738.07233.90343.9331.78115.2437.36817.41925.9130-0.282-1.4710
Other Non-Current Liabilities 2.6472.97311.4213.65413.77913.99514.61411.26711.42812.27410.15310.73910.15910.1991.031146.9881.4591.6900000000
Total Non-Current Liabilities 179.097187.314208.08236.732195.01319.442216.938204.829206.873208.236230.758220.349217.673200.49196.319195.437207.937159.241123.30477.37189.05197.662072.18672.5610
Total Liabilities 972.311988.4461,014.756800.444877.364792.891934.594984.444950.581,021.273791.119602.319631.717686.021673.233757.172519.373569.091634.236515.273409.23555.8830407.998340.182267.621
Equity:
Preferred Stock 000000000000000001.55100000000
Common Stock 601.065601.065601.065601.202594.162594.162565.653565.653565.653565.653561.54561.54561.54561.54561.54561.54561.54561.54561.54401.1360.9360.90360.9360.9360.9
Retained Earnings 7,070.646,758.7216,951.6576,746.7476,664.066,568.0566,500.0126,367.6926,282.766,233.5376,259.2476,475.4466,954.8136,841.5156,260.1715,761.535,803.4545,613.3765,068.875,051.3034,866.7674,743.65502,610.2842,008.8852,193.313
Accumulated Other Comprehensive Income/Loss 003,854.989443.3943,655.732410.1012,896.305372.5492,868.411347.6442,788.679335.7452,769.19321.1692,761.637318.3232,763.277-1.5510.8483.0293.1292.1844,270.85900.450.45
Other Total Stockholders Equity 3,640.4183,694.684-200.8473,629.14-71.3643,170.187-71.3642,438.968-71.3642,786.61202,778.82602,767.6902,761.40402,765.15502,768.184364.221366.405-0.162364.335257.11772.689
Total Shareholders Equity 11,312.12311,054.47111,206.86410,977.08910,842.59110,742.5069,890.6069,744.8629,645.469,585.8029,609.4669,815.81210,285.54310,167.3059,583.3479,084.4749,128.278,938.528,396.4148,220.5875,595.0175,470.964,270.6973,335.5192,627.3522,627.352
Total Equity 11,312.12311,054.47111,206.86410,977.08910,842.59110,742.5069,890.4449,744.79,645.2989,585.649,609.3039,815.6510,285.3810,167.1429,583.1859,084.3129,128.1088,938.3588,396.2518,220.4245,594.8555,470.7984,270.6973,335.3572,627.192,627.19
Total Liabilities & Shareholders Equity 12,284.43512,042.91612,221.62111,952.55711,719.95411,715.02310,825.03810,729.14310,595.87710,606.91210,400.42210,417.96910,917.09710,853.16310,256.4189,841.4849,647.4819,507.4499,030.4888,735.6986,004.0856,026.6814,270.6973,743.3552,967.3722,894.81